About this trial
Pilot, controled, randomized study aiming to evaluate a plan for the prevention of risks related to epilepsy, 3 months after the last therapeutic patient education session. Two groups of patients will be compared: group "intervention" (consultation with the neurologist then a psychologist followed by a session dedicated to risk prevention ("Recognize and Manage risks") integrated into usual Therapeutic Patient Education (TPE) versus "control" group (usual consultations with the neurologist and usual TPE).
37 subjects per group will be included in this study.
Eligibility criteria
Qualifiers
Patient between 18 and 60 years old
Patient with poorly controlled epilepsy (persistence of seizures evolving for more than a year despite proper treatment) or patient seizure-free for over a year but for whom therapeutic patient education (TPE) would be beneficial according to the investigator..
Patient agreeing to participate in a therapeutic education program (TPE)
Disqualifiers
Epileptic patient who has already benefited from a TPE epilepsy program
Patients with major cognitive impairment
Patient under guardianship or legal protection (safeguard of justice)
Pregnant or breast-feeding women
Trial design
Treatments tested in this trial
- Risk prevention session
- Usual Therapeutic Patient Education (TPE) management